CSX financials
$46.93+0.36%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.94B | $3.48B | $3.51B | $3.59B | $3.57B | $3.42B | $3.54B | $3.62B | $3.70B | $3.68B | $3.68B | $3.57B |
| Gross profit | $3.94B | $3.48B | $3.51B | $3.59B | $3.57B | $3.42B | $3.54B | $3.62B | $3.29B | $3.68B | $3.68B | $3.57B |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 88.9% | 100.0% | 100.0% | 100.0% |
| Operating income | $1.51B | $1.25B | $1.11B | $1.09B | $1.28B | $1.04B | $1.11B | $1.35B | $1.45B | $1.34B | $1.31B | $1.26B |
| Net income | $1.00B | $807.0M | $720.0M | $694.0M | $829.0M | $646.0M | $733.0M | $894.0M | $963.0M | $880.0M | $882.0M | $828.0M |
| Net margin | 25.5% | 23.2% | 20.5% | 19.3% | 23.2% | 18.9% | 20.7% | 24.7% | 26.0% | 23.9% | 24.0% | 23.2% |
| Diluted EPS | $0.54 | $0.43 | $0.39 | $0.37 | $0.44 | $0.34 | $0.38 | $0.46 | $0.49 | $0.45 | $0.45 | $0.41 |
| EBITDA | $1.92B | $1.67B | $1.51B | $1.68B | $1.71B | $1.47B | $1.64B | $1.77B | $1.86B | $1.75B | $1.31B | $1.67B |
| Operating cash flow | $1.33B | $1.27B | $1.39B | $1.34B | $635.0M | $1.25B | $1.39B | $1.69B | $1.11B | $1.07B | $1.49B | $1.55B |
| Free cash flow | $751.0M | $729.0M | $709.0M | $607.0M | -$141.0M | $536.0M | $550.0M | $1.06B | $558.0M | $549.0M | $803.0M | $978.0M |
| Diluted shares | 1,859.0M | 1,862.0M | 1,864.0M | 1,867.0M | 1,869.0M | 1,892.0M | 1,922.0M | 1,940.0M | 1,948.0M | 1,962.0M | 1,970.0M | 1,999.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.01B | $964.0M | $670.0M | $612.0M | $387.0M | $1.14B |
| Short-term investments | $383.0M | $145.0M | $5.0M | $6.0M | $6.0M | $8.0M |
| Total debt | $19.04B | $19.11B | $19.04B | $19.16B | $19.17B | $19.13B |
| Total assets | $44.73B | $44.23B | $43.68B | $43.28B | $42.93B | $43.20B |
| Total liabilities | $30.64B | $30.65B | $30.52B | $30.52B | $30.55B | $31.02B |
| Shareholders' equity | $14.09B | $13.58B | $13.16B | $12.76B | $12.38B | $12.18B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology